Atrion Corporation

Equities

ATRI

US0499041053

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
420 ^USD	+6.33%		+5.04%	+10.88%

Apr. 09	Atrion Corporation Announces Not Stand for Re-Election of Hugh J. Morgan, Jr. as Member of Board	CI
Feb. 29	Atrion Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Atrion Corporation Announces Not Stand for Re-Election of Hugh J. Morgan, Jr. as Member of Board

April 09, 2024 at 06:03 am EDT

Atrion Corporation announced that Hugh J. Morgan, Jr., who has served as a member of Board since 1988, informed the Board when he was last elected for a three-year term that he had decided that he would not stand for re-election when his term expires at the 2024 annual meeting to be held on May 21, 2024.

Latest news about Atrion Corporation

Atrion Corporation Announces Not Stand for Re-Election of Hugh J. Morgan, Jr. as Member of Board	Apr. 09	CI
Atrion Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Earnings Flash (ATRI) ATRION CORPORATION Reports Q4 Revenue $43.6M	Feb. 29	MT
Earnings Flash (ATRI) ATRION CORPORATION Posts Q4 EPS $3.65	Feb. 29	MT
Atrion Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Atrion Keeps Quarterly Cash Dividend at $2.20 Per Share, Payable on March 29 to Shareholders of Record on March 15	Feb. 27	MT
Atrion Corporation Declares Quarterly Cash Dividend, Payable on March 29, 2024	Feb. 27	CI
North American Morning Briefing : S&P 500 Futures Ease From Nvidia-Inspired Record High	Feb. 23	DJ
Atrion Corporation Enters into an Amended and Restated Credit Agreement	Dec. 28	CI
Atrion Maintains Quarterly Dividend at $2.20 a Share, Payable Dec. 15 to Shareholders of Record on Dec. 1	Nov. 13	MT
Atrion Corporation Declares Quarterly Cash Dividend, Payable on December 15, 2023	Nov. 13	CI
Tranche Update on Atrion Corporation's Equity Buyback Plan announced on May 22, 2015.	Nov. 07	CI
Atrion Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Earnings Flash (ATRI) ATRION CORPORATION Posts Q3 Revenue $41.9M	Nov. 07	MT
Atrion Corporation Announces Election of Jeannette Bankes as Director	23-09-20	CI
Atrion Increases Dividend to $2.20 a Share From $2.15, Payable on Sept. 29 to Shareholders as of Sept. 15	23-08-22	MT
Tranche Update on Atrion Corporation's Equity Buyback Plan announced on May 22, 2015.	23-08-08	CI
Earnings Flash (ATRI) ATRION CORPORATION Posts Q2 Revenue $43.8M	23-08-08	MT
Earnings Flash (ATRI) ATRION CORPORATION Posts Q2 EPS $3.73	23-08-08	MT
Atrion Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
Atrion Retains Quarterly Dividend of $2.15 a Share, Payable June 30 to Shareholders of Record on June 15	23-05-23	MT
Atrion Corporation Declares Quarterly Dividend, Payable on June 30, 2023	23-05-23	CI
Tranche Update on Atrion Corporation's Equity Buyback Plan announced on May 22, 2015.	23-05-08	CI
Earnings Flash (ATRI) ATRION CORPORATION Posts Q1 Revenue $40M	23-05-08	MT
Atrion Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-08	CI

Chart Atrion Corporation

Duration

Period

More charts

Company Profile

Atrion Corporation develops and manufactures products, primarily for medical applications. The Company's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. It has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The Company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-05 - Q1 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ATRION CORPORATION	+10.88%	739M
ABBOTT LABORATORIES	-2.54%	186B
MEDTRONIC PLC	-1.85%	107B
BECTON, DICKINSON AND COMPANY	-4.26%	67.44B
DEXCOM, INC.	+1.39%	50.03B
CENCORA, INC.	+16.82%	47.81B
HOYA CORPORATION	+4.79%	41.03B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.49%	26.85B
WEST PHARMACEUTICAL SERVICES, INC.	+0.65%	25.82B
TERUMO CORPORATION	+16.55%	24.74B

Other Medical Equipment, Supplies & Distribution